U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Adult T-Cell Leukemia/Lymphoma

MedGen UID:
79117
•Concept ID:
C0280427
•
Neoplastic Process
Synonyms: Adult T-Cell Lymphoma/Leukemia Recurrent; HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia Recurrent; HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia Relapsed; Recurrent Adult T-Cell Lymphoma/Leukemia; Recurrent HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia; Relapsed HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia

Definition

The reemergence of adult T-cell leukemia/lymphoma after a period of remission [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Adult T-Cell Leukemia/Lymphoma

Professional guidelines

PubMed

Lenalidomide treatment for recurrent adult T-cell leukemia/lymphoma after allogeneic hematopoietic cell transplantation.
Tanaka T, Inamoto Y, Ito A, Watanabe M, Takeda W, Aoki J, Kim SW, Fukuda T
Hematol Oncol 2023 Aug;41(3):389-395. Epub 2022 Dec 19 doi: 10.1002/hon.3115. PMID: 36513602

Recent clinical studies

Etiology

Lenalidomide treatment for recurrent adult T-cell leukemia/lymphoma after allogeneic hematopoietic cell transplantation.
Tanaka T, Inamoto Y, Ito A, Watanabe M, Takeda W, Aoki J, Kim SW, Fukuda T
Hematol Oncol 2023 Aug;41(3):389-395. Epub 2022 Dec 19 doi: 10.1002/hon.3115. PMID: 36513602

Therapy

Lenalidomide treatment for recurrent adult T-cell leukemia/lymphoma after allogeneic hematopoietic cell transplantation.
Tanaka T, Inamoto Y, Ito A, Watanabe M, Takeda W, Aoki J, Kim SW, Fukuda T
Hematol Oncol 2023 Aug;41(3):389-395. Epub 2022 Dec 19 doi: 10.1002/hon.3115. PMID: 36513602
Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002.
Ishida T, Fujiwara H, Nosaka K, Taira N, Abe Y, Imaizumi Y, Moriuchi Y, Jo T, Ishizawa K, Tobinai K, Tsukasaki K, Ito S, Yoshimitsu M, Otsuka M, Ogura M, Midorikawa S, Ruiz W, Ohtsu T
J Clin Oncol 2016 Dec;34(34):4086-4093. Epub 2016 Sep 30 doi: 10.1200/JCO.2016.67.7732. PMID: 27621400

Prognosis

Lenalidomide treatment for recurrent adult T-cell leukemia/lymphoma after allogeneic hematopoietic cell transplantation.
Tanaka T, Inamoto Y, Ito A, Watanabe M, Takeda W, Aoki J, Kim SW, Fukuda T
Hematol Oncol 2023 Aug;41(3):389-395. Epub 2022 Dec 19 doi: 10.1002/hon.3115. PMID: 36513602
Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002.
Ishida T, Fujiwara H, Nosaka K, Taira N, Abe Y, Imaizumi Y, Moriuchi Y, Jo T, Ishizawa K, Tobinai K, Tsukasaki K, Ito S, Yoshimitsu M, Otsuka M, Ogura M, Midorikawa S, Ruiz W, Ohtsu T
J Clin Oncol 2016 Dec;34(34):4086-4093. Epub 2016 Sep 30 doi: 10.1200/JCO.2016.67.7732. PMID: 27621400

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...